Adeptus Health Inc. (ADPT) 52.15 $ADPT UCHealth to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Adeptus Health Inc. (ADPT) 52.15 $ADPT

UCHealth to enhance access to Emergency Care in Colorado in partnership with Adeptus Health
M2 - Tue Apr 21, 8:47AM CDT
Emergency room company Adeptus Health (NYSE:ADPT) reported on Tuesday the establishment of a partnership to improve access to high quality and convenient emergency medical care in Colorado with University of Colorado Health (UCHealth).
ADPT: 52.15 (-2.38)

UCHealth and Adeptus Health Announce Partnership to Enhance Access to Emergency Care in Colorado
PR Newswire - Tue Apr 21, 7:00AM CDT
University of Colorado Health (UCHealth) and Adeptus Health (NYSE: ADPT) today announced formation of a partnership to improve access to high quality and convenient emergency medical care in Colorado. Under the partnership, UCHealth will hold a majority stake in Adeptus Health's freestanding emergency rooms throughout Colorado Springs, northern Colorado and the Denver Metro area.
ADPT: 52.15 (-2.38)

Adaptec Up 98.4% Since SmarTrend Uptrend Call (ADPT)
Comtex SmarTrend(R) - Fri Apr 17, 9:44AM CDT
SmarTrend identified an Uptrend for Adaptec (NASDAQ:ADPT) on November 7th, 2011 at $25.84. In approximately 42 months, Adaptec has returned 98.37% as of today's recent price of $51.25.
ADPT: 52.15 (-2.38)

Adeptus Health to Announce First Quarter 2015 Financial Results
PR Newswire - Wed Apr 15, 7:30AM CDT
Adeptus Health Inc. (NYSE: ADPT), owner and operator of First Choice Emergency Room, the largest network of independent freestanding emergency rooms in the United States, today announced that it will release its first quarter 2015 financial results on Thursday, April 23, 2015.
ADPT: 52.15 (-2.38)

91.5% Return Seen to Date on SmarTrend Adaptec Call (ADPT)
Comtex SmarTrend(R) - Fri Apr 10, 9:17AM CDT
SmarTrend identified an Uptrend for Adaptec (NASDAQ:ADPT) on November 7th, 2011 at $25.84. In approximately 42 months, Adaptec has returned 91.48% as of today's recent price of $49.47.
ADPT: 52.15 (-2.38)

NYSE stocks posting largest percentage decreases
AP - Wed Apr 08, 1:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at 1 p.m.:
CEQP: 6.73 (+0.09), EMES: 51.50 (+0.20), FR.TO: 5.93 (-0.20), ICD: 8.07 (-0.13), PDS: 6.78 (+0.08), GEL: 47.60 (-0.90), BCEI: 24.50 (-0.20), LPI: 14.46 (+0.20), ADPT: 52.15 (-2.38), FNV.TO: 60.36 (-2.53), CPE: 8.62 (+0.12), AG: 4.85 (-0.13), LGF: 31.24 (+0.10), FNV: 49.41 (-1.75), OHI: 38.52 (+0.22), PD.TO: 8.31 (+0.07), TNK: 6.47 (+0.14)

84.3% Return Seen to Date on SmarTrend Adaptec Call (ADPT)
Comtex SmarTrend(R) - Thu Apr 02, 4:47PM CDT
SmarTrend identified an Uptrend for Adaptec (NASDAQ:ADPT) on November 7th, 2011 at $25.83. In approximately 41 months, Adaptec has returned 84.28% as of today's recent price of $47.61.
ADPT: 52.15 (-2.38)

Adeptus Health Hits 52-Week High on Top-Line Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 30, 12:30PM CDT
Shares of Adeptus Health Inc. (AFFX) scaled a new 52-week high of $50.62 on Mar 27, eventually closing a tad bit lower at $50.13.
ABMD: 69.31 (-0.40), INGN: 36.39 (-0.04), LMNX: 16.34 (-0.01), ADPT: 52.15 (-2.38)

Shares of ADPT Up 78.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 26, 11:22AM CDT
SmarTrend identified an Uptrend for Adaptec (NASDAQ:ADPT) on November 7th, 2011 at $25.84. In approximately 41 months, Adaptec has returned 78.70% as of today's recent price of $46.17.
ADPT: 52.15 (-2.38)

Adaptec Up 79.0% Since SmarTrend Uptrend Call (ADPT)
Comtex SmarTrend(R) - Thu Mar 19, 9:44AM CDT
SmarTrend identified an Uptrend for Adaptec (NASDAQ:ADPT) on November 7th, 2011 at $25.84. In approximately 41 months, Adaptec has returned 79.02% as of today's recent price of $46.25.
ADPT: 52.15 (-2.38)

Adaptec Has Returned 63.2% Since SmarTrend Recommendation (ADPT)
Comtex SmarTrend(R) - Thu Mar 12, 9:24AM CDT
SmarTrend identified an Uptrend for Adaptec (NASDAQ:ADPT) on November 7th, 2011 at $25.84. In approximately 41 months, Adaptec has returned 63.15% as of today's recent price of $42.15.
ADPT: 52.15 (-2.38)

Quarterly Report Card: Special Research on Magellan Health, Neostem, Ensign, USMD Holdings, and Adeptus Health
PR Newswire - Tue Mar 10, 7:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ENSG: 45.50 (-0.15), NBS: 2.88 (+0.06), USMD: 10.37 (-0.08), ADPT: 52.15 (-2.38), MGLN: 70.99 (-0.02)

4 Big-Volume Stocks to Trade for Breakouts
at The Street - Mon Mar 09, 1:10PM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
WUBA: 75.56 (+3.20), HABT: 33.00 (+0.55), VSLR: 14.33 (+0.36), ADPT: 52.15 (-2.38)

Adeptus Health Q4 Earnings Miss, Revenues in Line; Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 9:20AM CST
Operator of freestanding emergency rooms in the U.S., Adeptus Health Inc. (ADPT) announced fourth-quarter 2014 adjusted earnings per share (EPS) of 8 cents, which missed the Zacks Consensus Estimate by a couple of cents.
ABMD: 69.31 (-0.40), INGN: 36.39 (-0.04), LMNX: 16.34 (-0.01), ADPT: 52.15 (-2.38)

Adeptus Health's (ADPT) CEO Tom Hall on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 20, 10:22PM CST

ADPT: 52.15 (-2.38)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 11:46AM CST

UIHC: 20.78 (+0.18), TILE: 21.12 (+0.21), MELA: 1.52 (-0.14), IPAS: 1.21 (-0.02), HSTM: 29.05 (-0.15), ASTI: 1.07 (+0.04), CSLT: 7.85 (+0.36), GTS: 19.36 (-0.01), I: 11.87 (-0.08), ADPT: 52.15 (-2.38), BCC: 38.42 (-0.13), SMLR: 3.25 (+0.08), AXDX: 23.62 (+0.10), CLRX: 0.95 (unch), XTLB: 2.30 (unch), XENE: 14.25 (-0.66), BJRI: 50.54 (-1.00), ATRO: 76.14 (+1.39), IKGH: 1.88 (-0.13), OGEN: 0.97 (+0.09)

Adeptus Health ups revenues 108% in Q4
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 9:26AM CST

ADPT: 52.15 (-2.38)

Adeptus Health misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 6:22AM CST

ADPT: 52.15 (-2.38)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 112

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 25

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 163

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 80

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 278

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Preeclampsia: Key Insights for Expecting Parents

Updated Category News Views 46

Preeclampsia: Essential Insights for Expecting Parents Preeclampsia is a significant condition that often raises concerns among expecting parents. It manifests as a dangerous form of high blood pressure during pregnancy and can also surface postpartum. Understanding this condition is vital for ensuring the health and safety of both mother and child during this crucial...

Continue Reading
DTE Energy Enhances Reliability with Smart Grid Technology

Updated Category News Views 240

DTE Energy's Progress with Smart Grid Technology DTE Energy (NYSE:DTE) has announced impressive strides in enhancing energy reliability through its cutting-edge smart grid technology. This initiative has successfully prevented nearly 5,000 power interruptions and saved over 1.8 million outage minutes for customers this year, highlighting the technology's role in ensuring...

Continue Reading
Key Insider Transactions in Major US Companies Unveiled

Updated Category News Views 270

Significant Insider Trading Activities This article sheds light on the notable insider buying and selling events reported recently, reflecting the movements within major US stocks. Major Insider Purchases Berkshire Hathaway Inc. (NYSE: BRKa) has made headlines by increasing its stake in Verisign Inc. (NASDAQ: VRSN). Under the leadership of Warren E. Buffett, the company...

Continue Reading
Hull Tactical's Latest Research Paper Enhances Market Predictions

Updated Category News Views 135

Hull Tactical Releases Innovative Academic Research The Hull Tactical team is excited to unveil its latest academic paper, titled Micro Alphas, co-authored by a talented group including Blair Hull, Petra Bakosova, Francois Cocquemas, Euan Sinclair, and Petri Fast. This research introduces a fresh framework that focuses on utilizing weak yet collectively informative...

Continue Reading
Cyrano Therapeutics and KYORIN Join Forces for Smell Loss Treatment

Updated Category News Views 138

Cyrano Therapeutics and KYORIN Collaboration Overview Cyrano Therapeutics, a pioneer in regenerative medicine, has taken a significant step forward in addressing the challenge of post-viral loss of smell. The company has entered into an option agreement with KYORIN Pharmaceutical Co., Ltd. to develop CYR-064, a promising treatment candidate specifically designed for those...

Continue Reading